Skip to main content

Patient Travel Assistance Program

UnknownUnder review·Mar 20, 2026
Covers
transportationfinancial assistance
Enrollment cycle
unknown

Eligibility

Assistance is available for blood cancer patients, including those treated with defibrotide sodium for hepatic veno-occlusive disease following a stem-cell transplant. While various travel and co-pay programs are listed, specific financial and distance thresholds are not defined in the provided text.